ABVC BioPharma, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sonoma Pharmaceuticals, Inc.

Palisade Bio, Inc.

ABVC BioPharma, Inc.

Tempest Therapeutics, Inc.

Synaptogenix, Inc.

Kiora Pharmaceuticals, Inc.

Aptorum Group Ltd.

Artelo Biosciences, Inc.

ZyVersa Therapeutics, Inc.

Petros Pharmaceuticals, Inc.

Universe Pharmaceuticals, Inc.

Why is ABVC BioPharma, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is ABVC BioPharma, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

ABVC BioPharma, Inc.

85.44%

0.43

121.72%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.71%

EBIT Growth (5y)

0.47%

EBIT to Interest (avg)

-6.68

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.37

Sales to Capital Employed (avg)

0.06

Tax Ratio

0.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.05%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.87

EV to EBIT

-8.03

EV to EBITDA

-8.97

EV to Capital Employed

2.66

EV to Sales

36.06

PEG Ratio

Dividend Yield

ROCE (Latest)

-33.10%

ROE (Latest)

-36.79%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

NET SALES(HY)

At USD 0.8 MM has Grown at 57.17%

RAW MATERIAL COST(Y)

Fallen by -21.42% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 13.88 %

INVENTORY TURNOVER RATIO(HY)

Highest at 82.04 times

-10What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -1.29 MM has Fallen at -42.54%

NET PROFIT(Q)

At USD -1.25 MM has Fallen at -52.73%

Here's what is working for ABVC BioPharma, Inc.

Net Sales

At USD 0.8 MM has Grown at 57.17%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (USD MM)

Debt-Equity Ratio

Lowest at 13.88 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 82.04 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -21.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for ABVC BioPharma, Inc.

Pre-Tax Profit

At USD -1.29 MM has Fallen at -42.54%

over average net sales of the previous four periods of USD -0.9 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -1.25 MM has Fallen at -52.73%

over average net sales of the previous four periods of USD -0.82 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)